Long-Term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: An uncontrolled, open-label, single-arm follow-on study
Titel:
Long-Term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: An uncontrolled, open-label, single-arm follow-on study
Auteur:
Gathe Jr, Joseph C. Wood, Robin Sanne, Ian Dejesus, Edwin Dirk, Schürmann Gladysz, Andrzej Garris, Cindy Givens, Naomi Elston, Robert Yeo, Jane